Topical Ruxolitinib Lichen Planus
NCT03697460
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Lichen Planus
Interventions
DRUG:
INCB018424
Sponsor
Aaron R. Mangold